It’s up to businesses to determine AI’s destiny—whether AI is used to shorten the traditional workday and improve work-life ...

Follow live coverage from Milwaukee Journal Sentinel reporters on Day 4 of the trial of Milwaukee County Circuit Court Judge ...

As the reindustrialization wave gains momentum, organizations face the imperative to reshape their processes, placing resilience and risk management above mere expansion.

Buldak has made a name for itself by being one of the spiciest ramens available. Here are some ways to tone down the spice ...

Deliver Me from Nowhere” was never just about shaping a true story. It was about framing a pop culture legacy and then ...

More than 79,600 criminal cases are now caught in the courts backlog in England and Wales, new figures show. The Crown Court backlog has been at a record high since early 2023 and is projected to hit ...

Kalaris Therapeutics offers differentiated approach to neovascular AMD with its lead candidate TH103. Click here to read my ...

From exclusion in trials to misdiagnosis and unsafe dosing, startup TrialMe is tackling the systemic roots of women’s ...

In the CAPItello-291 trial of capivasertib plus fulvestrant, 73% of patients had already received a CDK4/6 inhibitor. As ...

A 67-year-old says a new £2,000 device, which is being studied by the NHS, has improved his sleep and allowed him to go back ...

Kyverna Therapeutics, Inc. shares surged on strong Phase 2 KYSA-8 data for Miv-cel in stiff person syndrome. Read why KYTX ...

The anti-CD40 antibody tegoprubart offers a tacrolimus-free immunosuppression option for preventing islet transplant ...